Search

Search Constraints

You searched for: Author/Creator Dixon, Jesse G.

Search Results

1. A phase 1 and randomized, placebo‐controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872. Issue 21 (10th July 2019)

2. End of induction positron emission tomography complete response (PET‐CR) as a surrogate for progression‐free survival in previously untreated follicular lymphoma. (2nd May 2022)